Track the Cinclus Pharma Holding AB (publ) share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Cinclus Pharma Holding AB (publ) has logged 8 reports. Market capitalisation: €556.6m. The latest transaction was filed on 8 June 2026 (Purchase). Among the most active insiders: Gösta Hiller. All data is accessible without an account.
8
Insider Decl.
n/a
Thresholds
€53,191
8 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Buys €53,191n/a Sells
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
6,000 shares@ €1.66820.0018% mcap100.0% of flowAktieISINISIN SE0020388577FI:A003X228-1
8 of 8 declarations
About Cinclus Pharma Holding AB (publ)
Cinclus Pharma Holding AB (publ) is a pharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).